Consortium

About T2EVOLVE

About T2EVOLVE

Public-private partnership to make rapid progress and a lasting impact.
All members of the T2EVOLVE consortium are innovators and pioneers in the field of immunotherapy, highly committed to bridge the existing gaps between research and clinical application in Europe and make the EU lead the promising engineered T-cell therapy movement.
The T2EVOLVE consortium

The T2EVOLVE Consortium

The T2EVOLVE consortium is being coordinated by the Universitätsklinikum Würzburg, Germany and Servier, France. The interdisciplinary T2EVOLVE consortium is made up of 27 European partners from nine different nations.

Partners include university and non-university research facilities, pharmaceutical and biotechnology companies, as well as regulatory authorities and patients and professional associations.

T2EVOLVE Consortium

Coordinator:

Prof Michael Hudecek, MD
Universitätsklinikum Würzburg, Germany

Leader:

Dr Hélène Negre, PhD
Servier, France
Share This